| Pharmaceutical active ingredients: |
| Estradiol ValerateNorethindrone |
| Available forms, composition and doses of Merigest Sequi: |
| Tablets; Oral; Estradiol Valerate; Norethindrone |
| Merigest Sequi medical category: |
| Human:EstrogensProgestins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03CA53 - Estradiol, combinationsG03FA01 - Norethisterone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Climesse | Estradiol Valerate; Norethindrone | Novartis |
| Estro-Pause N | Estradiol Valerate; Norethindrone | Adcock Ingram |
| Mericomb | Estradiol Valerate; Norethindrone | Novartis; Pierre Fabre |
| Mericomb Mite | Estradiol Valerate; Norethindrone | Novartis |
| Merigest | Estradiol Valerate; Norethindrone | Novartis; Pierre Fabre |
| Mesigyna | Estradiol Valerate; Norethindrone Enanthate | Bayer Schering Pharma |
| Mesigyna Instayect | Estradiol Valerate; Norethindrone Enanthate | Bayer Schering Pharma |
| Mesygina | Estradiol Valerate; Norethindrone Enanthate | Bayer Schering Pharma |
| Norigynon | Estradiol Valerate; Norethindrone Enanthate | Bayer Schering Pharma |
| Cyclacur | Estradiol Valerate; Norgestrel | Bayer Schering Pharma |